1. Home
  2. CARM vs GRNQ Comparison

CARM vs GRNQ Comparison

Compare CARM & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • GRNQ
  • Stock Information
  • Founded
  • CARM 2016
  • GRNQ 2013
  • Country
  • CARM United States
  • GRNQ Malaysia
  • Employees
  • CARM N/A
  • GRNQ N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • GRNQ EDP Services
  • Sector
  • CARM Health Care
  • GRNQ Technology
  • Exchange
  • CARM Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • CARM 7.7M
  • GRNQ 6.8M
  • IPO Year
  • CARM N/A
  • GRNQ 2018
  • Fundamental
  • Price
  • CARM $0.19
  • GRNQ $1.06
  • Analyst Decision
  • CARM Hold
  • GRNQ
  • Analyst Count
  • CARM 5
  • GRNQ 0
  • Target Price
  • CARM $0.90
  • GRNQ N/A
  • AVG Volume (30 Days)
  • CARM 956.5K
  • GRNQ 131.7K
  • Earning Date
  • CARM 05-13-2025
  • GRNQ 05-14-2025
  • Dividend Yield
  • CARM N/A
  • GRNQ N/A
  • EPS Growth
  • CARM N/A
  • GRNQ N/A
  • EPS
  • CARM N/A
  • GRNQ N/A
  • Revenue
  • CARM $19,964,000.00
  • GRNQ $3,190,761.00
  • Revenue This Year
  • CARM N/A
  • GRNQ N/A
  • Revenue Next Year
  • CARM N/A
  • GRNQ N/A
  • P/E Ratio
  • CARM N/A
  • GRNQ N/A
  • Revenue Growth
  • CARM 32.45
  • GRNQ N/A
  • 52 Week Low
  • CARM $0.14
  • GRNQ $0.80
  • 52 Week High
  • CARM $1.90
  • GRNQ $2.24
  • Technical
  • Relative Strength Index (RSI)
  • CARM 44.76
  • GRNQ 52.87
  • Support Level
  • CARM $0.14
  • GRNQ $1.00
  • Resistance Level
  • CARM $0.20
  • GRNQ $1.20
  • Average True Range (ATR)
  • CARM 0.02
  • GRNQ 0.14
  • MACD
  • CARM 0.00
  • GRNQ -0.00
  • Stochastic Oscillator
  • CARM 71.47
  • GRNQ 32.73

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

Share on Social Networks: